Yoko Fujita-Yamaguchi

Prof. Dr. Yoko Fujita-Yamaguchi


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2000 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
SLShu-Jian Liang
Shu-Jian Liang
NGNing Guo
Ning Guo
AWAnna M. Wu
Anna M. Wu
YFYoko Fujita-Yamaguchi
Yoko Fujita-Yamaguchi

1 February 2003
Verified
Journal Article
Closed access
DSDeepali Sachdev
Deepali Sachdev
SLShu-Lian Li
Shu-Lian Li
JHJulie S Hartell
Julie S Hartell
YFYoko Fujita-Yamaguchi
Yoko Fujita-Yamaguchi
JMJeffrey Miller
Jeffrey Miller
DYDouglas Yee
Douglas Yee

24 February 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RMRossana Mineo
Rossana Mineo
EFEpifanio Fichera
Epifanio Fichera
SLShu-Jian Liang
Shu-Jian Liang
YFYoko Fujita-Yamaguchi
Yoko Fujita-Yamaguchi

1 April 2000 in Growth Hormone & IGF Research
Verified
Journal Article
Closed access
PDF file
EFE. Fichera
E. Fichera
SLS. Liang
S. Liang
Zhao-dong XuZhao-dong Xu
Zhao-dong Xu
NGN. Guo
N. Guo
RMR. Mineo
R. Mineo
YFYoko Fujita-Yamaguchi
Yoko Fujita-Yamaguchi

7 June 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Pierluigi ScaliaPierluigi Scalia
Pierluigi Scalia
Stephen J. WilliamsStephen J. Williams
Stephen J. Williams
YFYoko Fujita-Yamaguchi
Yoko Fujita-Yamaguchi
Regulation of the human IGF2 gene displays multiple layers of control, which secures a genetically and epigenetically predetermined gene expression pattern throughout embryonal growth and postnatal life. These predominantly nuclear regulatory mechanisms converge on the function of the IGF2-H19 gene cluster on Chromosome 11 and ultimately affect IGF2 gene expression. Deregulation of such control checkpoints leads to the enhancement of IGF2 gene transcription and/or transcript stabilization, ultimately leading to IGF-II peptide overproduction. This type of anomaly is responsible for the effects observed in terms of both abnormal fetal growth and increased cell proliferation, typically observed in pediatric overgrowth syndromes and cancer. We performed a review of relevant experimental work on the mechanisms affecting the human IGF2 gene at the epigenetic, transcriptional and transcript regulatory levels. The result of our work, indeed, provides a wider and diversified scenario for IGF2 gene activation than previously envisioned by shedding new light on its extended regulation. Overall, we focused on the functional integration between the epigenetic and genetic machinery driving its overexpression in overgrowth syndromes and malignancy, independently of the underlying presence of loss of imprinting (LOI). The molecular landscape provided at last strengthens the role of IGF2 in cancer initiation, progression and malignant phenotype maintenance. Finally, this review suggests potential actionable targets for IGF2 gene- and regulatory protein target-degradation therapies.

27 October 2015 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YFYoko Fujita-Yamaguchi
Yoko Fujita-Yamaguchi
Affinity chromatography is an efficient method to isolate proteins by taking advantage of their affinities for specific molecules such as substrates, inhibitors, antigens, ligands, antibodies, and other interacting molecules including subunits. Nowadays, we take the effectiveness and excellence of this technology for granted. This essay will mainly cover the use of affinity chromatography based on my experience.